The role of immune cells and immune related genes in the tumor microenvironment of papillary thyroid cancer and their significance for immunotherapy
- PMID: 39103463
- PMCID: PMC11300445
- DOI: 10.1038/s41598-024-69187-9
The role of immune cells and immune related genes in the tumor microenvironment of papillary thyroid cancer and their significance for immunotherapy
Abstract
Papillary thyroid carcinoma (PTC) is the most common pathological type of thyroid cancer (THCA) and shows a better prognosis than other types. However, further research is needed to determine the risk of PTC. We herein used the CIBERSORT algorithm to analyze the gene-expression profile obtained from TCGA, estimated the infiltration ratio of 22 immune cell types in tumor tissues and normal tissues, analyzed the differential expression of immune-related genes, and identified immune cells and immune-related genes related to clinical progress and prognosis. We uncovered 12 immune cell types and nine immune-related genes that were closely correlated with TNM staging, and two immune cell types (activated NK cells and γδT cells) and one immune-related gene (CD40LG) that were associated with prognosis. After evaluation, four immune cell types could be used to determine low-risk PTC, with six immune cell types and six immune-related genes closely associated with high-risk PTC. The type and quantity of infiltrating immune cells in the microenvironment of PTC, as well as immune-related genes, appear to be closely related to tumor progression and can therefore be used as important indicators for the evaluation of patient prognosis. We posit that the study of immune cells and immune-related genes in the tumor microenvironment will facilitate the determination of low-risk PTC more accurately, and that this will greatly promote the development of high-risk PTC immunotherapy.
Keywords: CD40LG; Immune genes; PTC; Tumor microenvironment.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures






Similar articles
-
Tumor Mutation Burden Predicts Relapse in Papillary Thyroid Carcinoma With Changes in Genes and Immune Microenvironment.Front Endocrinol (Lausanne). 2021 Jun 23;12:674616. doi: 10.3389/fendo.2021.674616. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34248843 Free PMC article.
-
Immune microenvironment in papillary thyroid carcinoma: roles of immune cells and checkpoints in disease progression and therapeutic implications.Front Immunol. 2024 Sep 3;15:1438235. doi: 10.3389/fimmu.2024.1438235. eCollection 2024. Front Immunol. 2024. PMID: 39290709 Free PMC article. Review.
-
Development and validation of a ferroptosis-related prognostic model for the prediction of progression-free survival and immune microenvironment in patients with papillary thyroid carcinoma.Int Immunopharmacol. 2021 Dec;101(Pt A):108156. doi: 10.1016/j.intimp.2021.108156. Epub 2021 Oct 6. Int Immunopharmacol. 2021. PMID: 34624650
-
Fatty acid metabolism influences the immune microenvironment in papillary thyroid cancer and identifies SCD as a novel biomarker.Front Endocrinol (Lausanne). 2025 Feb 27;16:1534393. doi: 10.3389/fendo.2025.1534393. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40084144 Free PMC article.
-
Immune Landscape of Thyroid Cancers: New Insights.Front Endocrinol (Lausanne). 2021 Apr 27;11:637826. doi: 10.3389/fendo.2020.637826. eCollection 2020. Front Endocrinol (Lausanne). 2021. PMID: 33986723 Free PMC article. Review.
Cited by
-
Association Between Triglyceride-Glucose Index and Malignant Risk in Thyroid Nodules: A Cross-Sectional Analysis.J Inflamm Res. 2025 Aug 19;18:11285-11297. doi: 10.2147/JIR.S533131. eCollection 2025. J Inflamm Res. 2025. PMID: 40860940 Free PMC article.
-
Non-contrast computed tomography radiomics model to predict benign and malignant thyroid nodules with lobe segmentation: A dual-center study.World J Radiol. 2025 Jun 28;17(6):106682. doi: 10.4329/wjr.v17.i6.106682. World J Radiol. 2025. PMID: 40606044 Free PMC article.
-
Application and recent advances in conventional biomarkers for the prognosis of papillary thyroid carcinoma.Front Oncol. 2025 May 21;15:1598934. doi: 10.3389/fonc.2025.1598934. eCollection 2025. Front Oncol. 2025. PMID: 40469184 Free PMC article. Review.
-
The Application of microRNAs in Papillary Thyroid Cancer: A Bibliometric and Visualized Analysis.Int J Gen Med. 2024 Oct 15;17:4681-4699. doi: 10.2147/IJGM.S487239. eCollection 2024. Int J Gen Med. 2024. PMID: 39429957 Free PMC article.
-
Mechanisms of HIF1A-mediated immune evasion in gastric cancer and the impact on therapy resistance.Cell Biol Toxicol. 2024 Oct 10;40(1):87. doi: 10.1007/s10565-024-09917-x. Cell Biol Toxicol. 2024. PMID: 39384651 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical